Conal and Daclizumab Subcutaneous
Determining the interaction of Conal and Daclizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlorpheniramine / phenylephrine / pyrilamine
Brand name: Chlorex-A 12, Conal, MyHist-PD, Nalex A 12, Phena-Plus, Phena-S, Poly Hist PD, Ru-Hist Forte, Atrohist Pediatric, Rynatan-S Pediatric, R-Tannate Pediatric, Gelhist Pediatric, R-Tannate, Triotann-S, R-Tannamine Pediatric, Triotann-S Pediatric, Tanoral Pediatric, Equitan Pediatric, Triple Tannate Pediatric, Tri-Tannate, Tanamine Pediatric, Tri-Tannate Pediatric, Rhinatate Pediatric, Rhinatate, Url-Tannate Pediatric, Tritan, Tanamine, R-Tannamine, Tanoral, URL-Tannate, Triotann, Histatan, Triotann Pediatric, Tri-Gestan S, Tri-Hist Pediatric, Tri Tann Pediatric, Poly Hist Forte, AllerTan, Triplex AD
Synonyms: n.a.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conal-Dacogen
- Conal-Dacomitinib
- Conal-Dactinomycin
- Conal-Dactinomycin Injection
- Conal-Dactinomycin Intravenous
- Conal-Daklinza
- Daclizumab Subcutaneous-Concept DHA
- Daclizumab Subcutaneous-Concept OB
- Daclizumab Subcutaneous-Concept OB Capsules
- Daclizumab Subcutaneous-Concerta
- Daclizumab Subcutaneous-Conestat alfa
- Daclizumab Subcutaneous-Conex